In addition, it is known that the accumulation of ROS can drive mutagenesis in AML cells (reviewed in [40]), which could support a hypothesis that NFATC2‐driven superoxide accumulation is an enabling mechanism for further leukaemogenesis and may have a role in AML progression. This evidence concerns the gene NFATC2 and acute myeloid leukemia.